Related Experiment Videos

Interleukin-2 in outpatients with renal cell carcinoma: SCAPP1 trial

J M Tourani¹, P Grise, V Lucas

¹Oncology Unit, Laennec Hospital, Paris, France.

Cancer Biotherapy & Radiopharmaceuticals

|October 1, 1996

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Maintenance of PARP Inhibitor Rechallenge plus Bevacizumab in Patients with Platinum-Sensitive, Recurrent Ovarian Cancer Previously Treated with a PARP Inhibitor.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

From toxicity assessment to adaptive safety care: implementing comprehensive fast-track safety evaluation for anticancer drug development.

ESMO open·2025

Microtubule association induces a Mg-free apo-like ADP pre-release conformation in kinesin-1 that is unaffected by its autoinhibitory tail.

Nature communications·2025

Predictive value of BRCA1/RAD51C methylation in HGSOC - An ancillary study of the PAOLA-1/ENGOT-ov25 phase 3 trial.

European journal of cancer (Oxford, England : 1990)·2025

Financial toxicity and socioeconomic impact of cancer in Europe.

ESMO open·2025

Dostarlimab and niraparib in primary advanced ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

See all related articles